In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hannah Daniel

Reporter

Hannah joined Medtech Insight from HBW Insight in August 2022 and reports on cybersecurity, patent law and other facets of medical device regulation. Hannah is passionate about the intersection of science and communication and holds a bachelor’s degree in biology from Carnegie Mellon University.

Latest From Hannah Daniel

News We’re Watching: Smart Watch Blood Glucose Warning, $100M For Women’s Health, Zimmer Surgical Robot Clearance

This week, the FDA reminded consumers that smart watches and rings are not blood glucose monitors; First Lady Jill Biden announced a $100M women’s health initiative; and the Zimmer ROSA Shoulder System got FDA clearance.

Regulation Digital Health

AdvaMed Principles For Artificial Intelligence Focus On Patient, Physician Needs

AdvaMed’s principles for artificial intelligence deb focus on using the technology to meet patient needs.

Digital Health Regulation

Da Vinci Surgical Robot Insulation Defects Led To Florida Woman’s Death, Lawsuit Alleges

Intuitive Surgical is facing claims that malfunctions of its da Vinci surgical robot led to a woman’s death following a laparoscopic surgery.

Legal Issues Regulation

Masimo’s MightySat Receives First FDA Clearance For OTC Pulse Oximeter

The first clearance from the US Food and Drug Administration for an over-the-counter fingertip pulse oximeter has gone to Masimo's MightySat Medical, which is now available at the company's website.

Approvals Patient Monitoring

HHS Releases ‘Essential’ And ‘Enhanced’ Cybersecurity Performance Goals

HHS publishes a new website and releases its essential and enhanced voluntary cybersecurity performance goals.

Cybersecurity Digital Health

US FDA’s Needs To Fortify Supply Chain Among Legislative Priorities In 2025 Budget

As the FDA’s Office of Policy, Legislation and International Affairs finalizes the agency’s yearly budget, it already is looking ahead to next year. 

Legislation Policy
See All
UsernamePublicRestriction

Register